Trials / Completed
CompletedNCT02632578
Influenza Vaccine in HIV Study
A Comparison of Immune Responses to the Licensed Trivalent Inactivated Influenza Vaccine in HIV-positive and HIV-negative Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 57 (actual)
- Sponsor
- University of Melbourne · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The aims of this study are: 1. to investigate if HIV infection alters the antibody responses to influenza and 2. to assess the ability of licensed influenza vaccine to induce functional non-neutralising antibodies in HIV-infected and HIV-uninfected subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | 2015 Fluvax® vaccine, BioCSL (a licensed influenza vaccine) | Subjects received licensed influenza vaccine (Fluvax®), 1ml intramuscular injection. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-06-01
- Completion
- 2015-12-01
- First posted
- 2015-12-16
- Last updated
- 2015-12-16
Source: ClinicalTrials.gov record NCT02632578. Inclusion in this directory is not an endorsement.